TrialInternational journal of radiation oncology, biology, physics2026

Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG/RTOG 1016 Randomized Controlled Trial.

Jolie Ringash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.